Tenofovir in second-line ART in Zambia and South Africa: collaborative analysis of cohort studies
Publisher DOI
PubMed ID
22743595
Abstract
Tenofovir (TDF) is increasingly used in second-line antiretroviral treatment (ART) in sub-Saharan Africa. We compared outcomes of second-line ART containing and not containing TDF in cohort studies from Zambia and the Republic of South Africa (RSA).
Date Issued
2012
Publication Type
Article
Subject(s)
Language(s)
en
Author(s)
Mulenga, Lloyd | |
Hoffmann, Christopher J | |
Wood, Robin | |
Chaweza, Thom | |
Brennan, Alana | |
Prozesky, Hans | |
Garone, Daniela | |
Giddy, Janet | |
Chimbetete, Cleophas | |
Boulle, Andrew | |
IeDEA Southern Africa Collaboration |
Additional Credits
Journal
Journal of acquired immune deficiency syndromes JAIDS
Publisher
Lippincott Williams & Wilkins
ISSN
0894-9255
Access(Rights)
open.access